Behçet's syndrome: one year in review 2025

Behçet's syndrome (BS) is a variable-vessel vasculitis with multiorgan involvement and heterogeneous clinical manifestations. A list of studies were published on BS last year including studies that explore the epidemiology of BS in different parts of the world, role of potential immunological biomarkers in major organ involvement phenotypes, genome wide association studies, studies on micro RNAs, toll like receptors, neutrophil function and epigenetics that added to our understanding of the pathogenesis, studies on imaging and clinical findings that aim to improve diagnosis, differential diagnosis, and monitoring of each organ involvement, as well as studies on management, especially focusing on the role of TNF inhibitors compared to conventional immunosuppressives. The aim of this review is to provide a critical digest of the studies on BS published during 2024.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Rheumatology
Published
2025-10-23
DOI
https://doi.org/10.55563/clinexprheumatol/8xuim0
Primary Topic
Ocular Diseases and Behçet’s Syndrome
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Behçet's syndrome: one year in review 2025

İzzet Fresko, Rosaria Talarico, Didar Uçar, Gülen Hatemi et al.
Clinical and Experimental Rheumatology
Ocular Diseases and Behçet’s Syndrome
article

Behçet's syndrome: one year in review 2025

İzzet Fresko, Rosaria Talarico, Didar Uçar, Gülen Hatemi, Emire Seyahi, Vedat Hamuryudan
article en

Abstract

Behçet's syndrome (BS) is a variable-vessel vasculitis with multiorgan involvement and heterogeneous clinical manifestations. A list of studies were published on BS last year including studies that explore the epidemiology of BS in different parts of the world, role of potential immunological biomarkers in major organ involvement phenotypes, genome wide association studies, studies on micro RNAs, toll like receptors, neutrophil function and epigenetics that added to our understanding of the pathogenesis, studies on imaging and clinical findings that aim to improve diagnosis, differential diagnosis, and monitoring of each organ involvement, as well as studies on management, especially focusing on the role of TNF inhibitors compared to conventional immunosuppressives. The aim of this review is to provide a critical digest of the studies on BS published during 2024.

Clinical and Experimental RheumatologyVol. 43(10)
University of Pisa (IT), Istanbul University-Cerrahpaşa (TR), Istanbul University (TR)
Openalex Percentile: Top 56%
Ocular Diseases and Behçet’s Syndrome
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Behçet's syndrome: one year in review 2025 — İzzet Fresko, Rosaria Talarico, et al. · Clinical and Experimental Rheumatology (2025) | TGRS Research Map | TGRS